Our data support a role for STAT5 inhibition in PTCL and implicate potential utility for inhibition of STAT5 and activation of the extrinsic apoptotic pathway as combination therapy in PTCL. Here, STAT5B is linked to mature T-cell and NK-cell non-Hodgkin lymphoma.